• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First description of a TEM-30 (IRT-2)-producing Klebsiella oxytoca isolate.

作者信息

Granier Sophie A, Nguyen Van Jean-Claude, Kitzis Marie-Dominique, Goldstein Fred W, Leflon-Guibout Véronique, Nicolas-Chanoine Marie-Hélène

出版信息

Antimicrob Agents Chemother. 2002 Apr;46(4):1158-9. doi: 10.1128/AAC.46.4.1158-1159.2002.

DOI:10.1128/AAC.46.4.1158-1159.2002
PMID:11897614
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC127080/
Abstract
摘要

相似文献

1
First description of a TEM-30 (IRT-2)-producing Klebsiella oxytoca isolate.首次描述产 TEM-30（IRT-2）的产酸克雷伯菌分离株。
Antimicrob Agents Chemother. 2002 Apr;46(4):1158-9. doi: 10.1128/AAC.46.4.1158-1159.2002.
2
Identification of clinical isolates of indole-positive Klebsiella spp., including Klebsiella planticola, and a genetic and molecular analysis of their beta-lactamases.吲哚阳性克雷伯菌属临床分离株的鉴定，包括植生克雷伯菌，及其β-内酰胺酶的遗传和分子分析。
J Clin Microbiol. 1997 Sep;35(9):2365-9. doi: 10.1128/jcm.35.9.2365-2369.1997.
3
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.一种独特的头孢他啶水解β-内酰胺酶TEM-E2的特性分析。
J Med Microbiol. 1990 Jun;32(2):131-4. doi: 10.1099/00222615-32-2-131.
4
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.产酸克雷伯菌临床分离株中新型耐抑制剂TEM衍生β-内酰胺酶TEM-59（IRT-17）的分子特征
Antimicrob Agents Chemother. 1999 Jul;43(7):1657-61. doi: 10.1128/AAC.43.7.1657.
5
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals.加拿大医院中产生安布勒A类超广谱β-内酰胺酶的大肠杆菌和克雷伯菌属。
Antimicrob Agents Chemother. 2004 Apr;48(4):1204-14. doi: 10.1128/AAC.48.4.1204-1214.2004.
6
Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?使用市售的MicroScan微量稀释板获得的结果能否作为大肠埃希菌和克雷伯菌分离株中β-内酰胺酶产生的指标，这些分离株对广谱头孢菌素和氨曲南存在隐匿性耐药？
J Clin Microbiol. 1998 Sep;36(9):2575-9. doi: 10.1128/JCM.36.9.2575-2579.1998.
7
[Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].[头孢克肟在肠杆菌科细菌产生的β-内酰胺酶类型存在时的抗菌作用]
Presse Med. 1989 Oct 11;18(32):1560-6.
8
Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family.产酸克雷伯菌的超广谱β-内酰胺酶，不属于TEM或SHV家族。
J Antimicrob Chemother. 1992 Jul;30(1):3-16. doi: 10.1093/jac/30.1.3.
9
Extended spectrum beta lactamase production & multidrug resistance in Klebsiella species isolated from children under five with intestinal & extraintestinal infections.从五岁以下患有肠道和肠外感染的儿童中分离出的克雷伯菌属中产超广谱β-内酰胺酶及多重耐药情况
Indian J Med Res. 2001 May;113:181-5.
10
Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.欧洲败血症分离株中大肠杆菌和克雷伯菌属的超广谱β-内酰胺酶
J Antimicrob Chemother. 1993 Oct;32(4):559-70. doi: 10.1093/jac/32.4.559.

引用本文的文献

1
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.产酸克雷伯菌复合体：分类学、抗菌耐药性和毒力的最新研究进展。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0000621. doi: 10.1128/CMR.00006-21. Epub 2021 Dec 1.
2
Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a University Hospital in Barcelona, Spain, over a 3-year period.西班牙巴塞罗那一家大学医院在3年时间里产抑制剂耐药β-内酰胺酶大肠埃希菌临床分离株的流行情况。
Antimicrob Agents Chemother. 2002 Dec;46(12):3991-4. doi: 10.1128/AAC.46.12.3991-3994.2002.

本文引用的文献

1
Updated sequence information and proposed nomenclature for bla(TEM) genes and their promoters.bla(TEM)基因及其启动子的更新序列信息和建议命名法。
Antimicrob Agents Chemother. 2000 Nov;44(11):3232-4. doi: 10.1128/AAC.44.11.3232-3234.2000.
2
Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.对大肠杆菌、肺炎克雷伯菌和产酸克雷伯菌临床分离株进行超广谱β-内酰胺酶（ESBL）的筛查和确证试验。
Diagn Microbiol Infect Dis. 2000 Feb;36(2):113-7. doi: 10.1016/s0732-8893(99)00117-0.
3
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.产酸克雷伯菌临床分离株中新型耐抑制剂TEM衍生β-内酰胺酶TEM-59（IRT-17）的分子特征
Antimicrob Agents Chemother. 1999 Jul;43(7):1657-61. doi: 10.1128/AAC.43.7.1657.
4
Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.产酸克雷伯菌产生的耐抑制剂的OXY-2衍生β-内酰胺酶。
Antimicrob Agents Chemother. 1998 Sep;42(9):2184-7. doi: 10.1128/AAC.42.9.2184.
5
Discriminatory detection of inhibitor-resistant beta-lactamases in Escherichia coli by single-strand conformation polymorphism-PCR.通过单链构象多态性聚合酶链反应鉴别检测大肠杆菌中耐抑制剂的β-内酰胺酶
Antimicrob Agents Chemother. 1998 Apr;42(4):879-84. doi: 10.1128/AAC.42.4.879.
6
Phylogeny of mercury resistance (mer) operons of gram-negative bacteria isolated from the fecal flora of primates.从灵长类动物粪便菌群中分离出的革兰氏阴性菌汞抗性（mer）操纵子的系统发育。
Appl Environ Microbiol. 1997 Mar;63(3):1066-76. doi: 10.1128/aem.63.3.1066-1076.1997.
7
Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2.产酸克雷伯菌的染色体β-内酰胺酶基因分为两个主要组，blaOXY-1和blaOXY-2。
Antimicrob Agents Chemother. 1996 Feb;40(2):454-9. doi: 10.1128/AAC.40.2.454.
8
A survey of beta-lactamases from 618 isolates of Klebsiella spp.对618株克雷伯菌属分离株的β-内酰胺酶进行的一项调查
J Antimicrob Chemother. 1993 Jan;31(1):29-35. doi: 10.1093/jac/31.1.29.
9
Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.肺炎克雷伯菌中β-内酰胺酶过量产生的分子基础——普里布诺框中的点突变
Antimicrob Agents Chemother. 1995 Jun;39(6):1365-8. doi: 10.1128/AAC.39.6.1365.
10
Incompatibility groups and the classification of fi - resistance factors.不相容性群与抗噬菌体因子的分类。
J Bacteriol. 1972 Nov;112(2):666-75. doi: 10.1128/jb.112.2.666-675.1972.